Commercialization advisory board

The VCU Commercialization Advisory Board includes industry experts, early-stage investors and entrepreneurs who provide guidance and recommendations for critical commercialization and investment decisions.

The board reviews technologies and judges inventors’ presentations based on various factors, including patentability, stage of development, unmet market need, industry feedback and societal impact.

Geoffrey D. Beecher [View Image]

Geoffrey D. Beecher

Mid-Atlantic sales manager

Focal Therapeutics

Expertise: Medical devices

Reinhold Brand [View Image]

Reinhold Brand

President (retired)

Evonic USA

Expertise: Material sciences & specialty chemicals

[View Image]

Chandra Briggman

President / CEO

Activation Capital

Expertise: Innovation ecosystems

[View Image]

Kevin Corby

Research and development director (retired)

DuPont

Expertise: Industrial chemistry

William Daugtry Headshot [View Image]

William Daughtry

Group managing partner (retired)

PWC

Expertise: Finance & advising early stage companies

[View Image]

Sam English

Founder & managing partner

CIE Partners

Expertise: Research commercialization & entrepreneurial ecosystem building

Alex Euler [View Image]

Alex Euler

Investment director

CIT Gap Fund

Expertise: Life sciences

Anthony Fung headshot [View Image]

Anthony Fung

CEO

GovInsight

Expertise: IT & government

Jeffrey M. Gallagher [View Image]

Jeffrey M. Gallagher

Not-for-profit manager

Community leader

Expertise: Life sciences & corporate law

[View Image]

Tracey Greene

Founding executive director

Charlottesville Angel Network

Expertise: Technology innovation, entrepreneurship, and early stage investments

Omar Khalil Headshot [View Image]

Omar Khalil

Vice president & general manager

Kaleo

Expertise: Pharma, medical devices, and venture capital

Mark Lambert Headshot [View Image]

Mark Lambert

Founder

VArtisans

Expertise: Virtual reality & film industry

Chris Little Headshot [View Image]

Chris Little

Founder

SingleStone

Expertise: Software

William McPheat Headshot [View Image]

William McPheat

Principle scientist (retired)

AstraZeneca

Expertise: Pharma & cardiovascular drug development

John Newby Headshot [View Image]

John Newby

CEO

Virginia Bio

Expertise: Life sciences, patent law, and government

[View Image]

Kevin Passarello

Shareholder

Buchanan Ingersoll & Rooney PC

Expertise: Early stage investments

[View Image]

Richard Pellegrino

Sr. Director global innovation

Stryker

Expertise: Medical devices

Dennis Schafer [View Image]

Dennis Schafer

Director

Life Science Management

Expertise: Pharma & serial entrepreneurship

[View Image]

William Weber

VP and general manager (retired)

DuPont

Expertise: Chemical industry

[View Image]

Vida Williams

Advanced analytics solution lead

SingleStone

Expertise: Big data & data science